Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: A pilot study

Neurochemical Research

Volumn 36, Issue 11, 2011, Pages 2111-2115

  Martínez Hernández, Rubén ^a   Montes, Sergio ^a   Higuera Calleja, Jesus ^b   Yescas, Petra ^a   Boll, Marie Catherine ^a   Diaz Ruiz, Araceli ^a   Rios, Camilo ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Ceruloplasmin; Ferroxidase activity; Parkinson's disease; Plasma; Sonographic area; Substantia nigra

Indexed keywords

CERULOPLASMIN;

ADULT; ARTICLE; BIOACCUMULATION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DOPPLER ECHOGRAPHY; ENZYME ACTIVITY; FEMALE; HUMAN; IRON METABOLISM; MALE; NEUROIMAGING; PARKINSON DISEASE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

ADULT; AGED; CERULOPLASMIN; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; PARKINSON DISEASE; PILOT PROJECTS; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 80054992416     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0535-x     Document Type: Article

References (22)

1. CM Tanner DA Aston 2000 Epidemiology of Parkinson's disease and akinetic syndromes Curr Opin Neurol 13 427 430 10970060 10.1097/00019052-200008000-00010 1:STN:280:DC%2BD3M%2Fmt1Kntw%3D%3D
2. AJ Hughes SE Daniel L Kilford AJ Lees 1992 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184 1564476 10.1136/jnnp.55.3.181 1:STN:280:DyaK383is1Omsg%3D%3D
3. D Berg C Siefker G Becker 2001 Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings J Neurol 248 684 689 11569897 10.1007/s004150170114 1:STN:280:DC%2BD3MritFWltQ%3D%3D (Pubitemid 32695865)
4. U Walter D Dressler A Wolters M Wittstock R Benecke 2007 Transcranial brain sonography findings in clinical subgroups of Idiopathic Parkinson's disease Mov Disord 22 48 54 17083096 10.1002/mds.21197 (Pubitemid 46382672)
5. L Zecca D Berg T Arzberger P Ruprecht WD Rausch M Musicco D Tampellini P Riederer M Gerlach G Becker 2005 In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage Mov Disord 20 1278 1285 15986424 10.1002/mds.20550 (Pubitemid 41645902)
6. C Mukhopadhyay ZK Attieh PL Fox 1998 Role of ceruloplasmin in cellular iron uptake Science 279 714 717 9445478 10.1126/science.279.5351.714 1:CAS:528:DyaK1cXovVGiuw%3D%3D (Pubitemid 28144552)
7. K Tajima T Kawanami R Nagai S Horiuchi T Kato 1999 Hereditary ceruloplasmin deficiency increases advanced glycation end products in the brain Neurology 53 619 622 10449130 1:CAS:528:DyaK1MXlsleisrs%3D (Pubitemid 29382061)
8. MC Boll J Sotelo E Otero M Alcaraz-Zubeldia C Rios 1999 Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease Neurosci Lett 265 155 158 10327154 10.1016/S0304-3940(99)00221-9 1:CAS:528:DyaK1MXjtVSnsb8%3D (Pubitemid 29207389)
9. G Tórsdóttir J Kristinsson S Sveinbjörnsdóttir J Snaedal T Jóhannesson 1999 Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease Pharmacol Toxicol 85 239 243 10608487 10.1111/j.1600-0773.1999.tb02015.x
10. H Hochstrasser J Tomiuk U Walter S Behnke J Spiegel R Krüger G Becker O Riess D Berg 2005 Functional relevance of ceruloplasmin mutations in Parkinson's disease FASEB J 19 1851 1853 16150804 1:CAS:528:DC%2BD2MXht1emsbrF (Pubitemid 41598772)
11. D Berg S Behnke U Walter 2006 Application of transcranial sonography in extrapyramidal disorders: updated recommendations Ultraschall Med 27 12 19 16470475 10.1055/s-2005-858962 1:STN:280:DC%2BD287ks1KisQ%3D%3D (Pubitemid 43342730)
12. S Tanabe T Shioiri K Murakami T Imanari 1984 A new method for assay of ferroxidase activity and its application to human and rabbit sera Chem Pharm Bull (Tokio) 32 4029 4035 1:CAS:528:DyaL2MXktF2isA%3D%3D
13. J Prestel KJ Schweitzer A Hofer T Gasser D Berg 2006 Predictive value of transcranial sonography in the diagnosis of Parkinson's disease Mov Disord 21 1763 1765 16874758 10.1002/mds.21054 (Pubitemid 44742216)
14. U Walter L Niehaus T Probst R Benecke BU Meyer D Dressler 2003 Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes Neurology 60 74 77 12525721 1:STN:280: DC%2BD3s%2FhvFehtw%3D%3D (Pubitemid 36070647)
15. CF Tsai RM Wu YW Huang LL Chen PK Yip JS Jeng 2007 Transcranial color coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism J Neurol 254 501 507 17401518 10.1007/s00415-006-0403- 9 (Pubitemid 46786727)
16. U Walter M Wittstock R Benecke D Dressler 2002 Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease J Neural Transm 109 191 196 12075859 10.1007/s007020200015 1:STN:280:DC%2BD38zjt1Gqsg%3D%3D (Pubitemid 34185665)
17. U Walter D Dressler A Wolters T Probst A Grossmann R Benecke 2004 Sonographic discrimination of corticobasal degeneration vs. progressive supranuclear palsy Neurology 63 504 509 15304582 1:STN:280: DC%2BD2cvgtFKqsg%3D%3D (Pubitemid 39031381)
18. L Zecca MB Youdim P Riederer JR Connor RR Crichton 2004 Iron, brain ageing and neurodegenerative disorders Nat Rev Neurosci 5 863 873 15496864 10.1038/nrn1537 1:CAS:528:DC%2BD2cXos1Ojtrc%3D (Pubitemid 39482155)
19. D Berg M Gerlach MB Youdim KL Double L Zecca P Riederer G Becker 2001 Brain iron pathways and their relevance to Parkinson's disease J Neurochem 79 225 236 11677250 10.1046/j.1471-4159.2001.00608.x 1:CAS:528:DC%2BD3MXnvFSmsr8%3D (Pubitemid 32988938)
20. P Jenner 2003 Oxidative stress in Parkinson's disease Ann Neurol 53 Suppl 3 S26 S38 12666096 10.1002/ana.10483 1:CAS:528:DC%2BD3sXjtFGitLs%3D (Pubitemid 36368560)
21. S Rivera-Mancía I Pérez-Neri C Ríos L Tristán-López L Rivera-Espinosa S Montes 2010 The transition metals copper and iron in neurodegenerative diseases Chem Biol Interact 186 184 199 20399203 10.1016/j.cbi.2010.04.010
22. L Jin J Wang L Zhao H Jin G Fei Y Zhang M Zeng C Zhong 2011 Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease Brain 134 50 58 21109502 10.1093/brain/awq319